🇺🇸 FDA
Patent

US 9486457

Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders

granted A61KA61K31/538A61P

Quick answer

US patent 9486457 (Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders) held by The Regents of the University of California expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/538, A61P, A61P1/16, A61P17/00